Search

2 Feb 2022: £1.5m investment via Crowdcube and Cambridge Enterprise creates new jobs and further development of the tech.

9 May 2022: KARPAS 707H Human myeloma cell line suitable for the generation of stable human hybridomas for the creation of fully human monoclonal antibodies.

10 May 2022: Here are some ideas:. Performance/applications data. Prototype development, scale-up of process, develop new applications. ... parties. Example of a benefit statement. We can help primary school teachers teach children to speak a new language more

15 Mar 2022: Impact Insight video case study: Kalamna toolkit. The third in our new series of Impact Insight videos focuses on the licensing of the Kalamna toolkit for learning Arabic. ... Dr Khalil has spent her career researching how young Arabic learners can be

9 May 2022: KARPAS 1272 Human Myeloma cell line, useful in oncology research, developed at the University of Cambridge.

18 Aug 2022: with the potential to provide tens of thousands of new jobs over the next few years.

12 Oct 2022: Chris Gibbs shares his perspectives on the importance of sustainability, investing in sustainability businesses and building entrepreneurial mindsets through the Carbon Challenge.

11 Apr 2022: A new class of battery technology. Nyobolt’s team of experts has pioneered a new class of battery technology that achieves record-breaking ultra-fast charging.

15 Dec 2022: Market-based solutions comprise many arrangements, such as licensing innovative tools, creating new companies (including social ventures), carrying out consultancies, and bringing. ... The above reduces the possibilities that usually originate from

9 May 2022: KARPAS 241 Human Monoblastic cell line useful in oncology research, developed at the University of Cambridge.